Literature DB >> 22452338

Comparative effectiveness of revascularization strategies.

William S Weintraub1, Maria V Grau-Sepulveda, Jocelyn M Weiss, Sean M O'Brien, Eric D Peterson, Paul Kolm, Zugui Zhang, Lloyd W Klein, Richard E Shaw, Charles McKay, Laura L Ritzenthaler, Jeffrey J Popma, John C Messenger, David M Shahian, Frederick L Grover, John E Mayer, Cynthia M Shewan, Kirk N Garratt, Issam D Moussa, George D Dangas, Fred H Edwards.   

Abstract

BACKGROUND: Questions persist concerning the comparative effectiveness of percutaneous coronary intervention (PCI) and coronary-artery bypass grafting (CABG). The American College of Cardiology Foundation (ACCF) and the Society of Thoracic Surgeons (STS) collaborated to compare the rates of long-term survival after PCI and CABG.
METHODS: We linked the ACCF National Cardiovascular Data Registry and the STS Adult Cardiac Surgery Database to claims data from the Centers for Medicare and Medicaid Services for the years 2004 through 2008. Outcomes were compared with the use of propensity scores and inverse-probability-weighting adjustment to reduce treatment-selection bias.
RESULTS: Among patients 65 years of age or older who had two-vessel or three-vessel coronary artery disease without acute myocardial infarction, 86,244 underwent CABG and 103,549 underwent PCI. The median follow-up period was 2.67 years. At 1 year, there was no significant difference in adjusted mortality between the groups (6.24% in the CABG group as compared with 6.55% in the PCI group; risk ratio, 0.95; 95% confidence interval [CI], 0.90 to 1.00). At 4 years, there was lower mortality with CABG than with PCI (16.4% vs. 20.8%; risk ratio, 0.79; 95% CI, 0.76 to 0.82). Similar results were noted in multiple subgroups and with the use of several different analytic methods. Residual confounding was assessed by means of a sensitivity analysis.
CONCLUSIONS: In this observational study, we found that, among older patients with multivessel coronary disease that did not require emergency treatment, there was a long-term survival advantage among patients who underwent CABG as compared with patients who underwent PCI. (Funded by the National Heart, Lung, and Blood Institute.).

Entities:  

Mesh:

Year:  2012        PMID: 22452338      PMCID: PMC4671393          DOI: 10.1056/NEJMoa1110717

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  28 in total

1.  Surgical candidacy and selection biases in nonemergent left main stenting: implications for observational studies.

Authors:  Edward J McNulty; William Ng; John A Spertus; Jonathan G Zaroff; Robert W Yeh; Xiushi M Ren; Robert J Lundstrom
Journal:  JACC Cardiovasc Interv       Date:  2011-09       Impact factor: 11.195

2.  Late outcome after stenting or coronary artery bypass surgery for the treatment of multivessel disease: a single-center matched-propensity controlled cohort study.

Authors:  Ron T van Domburg; Johanna J M Takkenberg; Leo J Noordzij; Francesco Saia; Lex A van Herwerden; Patrick W J C Serruys; Ad J J C Bogers
Journal:  Ann Thorac Surg       Date:  2005-05       Impact factor: 4.330

3.  Assessing the sensitivity of regression results to unmeasured confounders in observational studies.

Authors:  D Y Lin; B M Psaty; R A Kronmal
Journal:  Biometrics       Date:  1998-09       Impact factor: 2.571

4.  A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST)

Authors:  S B King; N J Lembo; W S Weintraub; A S Kosinski; H X Barnhart; M H Kutner; N P Alazraki; R A Guyton; X Q Zhao
Journal:  N Engl J Med       Date:  1994-10-20       Impact factor: 91.245

5.  Five-year outcome after coronary angioplasty versus bypass surgery in multivessel coronary artery disease: results from the French Monocentric Study.

Authors:  D Carrié; M Elbaz; J Puel; J Fourcade; E Karouny; G Fournial; M Galinier
Journal:  Circulation       Date:  1997-11-04       Impact factor: 29.690

6.  Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.

Authors:  Whady Hueb; Neuza Helena Lopes; Bernard J Gersh; Paulo Soares; Luiz A C Machado; Fabio B Jatene; Sergio A Oliveira; Jose A F Ramires
Journal:  Circulation       Date:  2007-03-06       Impact factor: 29.690

7.  First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation). CABRI Trial Participants.

Authors: 
Journal:  Lancet       Date:  1995-11-04       Impact factor: 79.321

8.  Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial.

Authors: 
Journal:  Lancet       Date:  1993-03-06       Impact factor: 79.321

9.  A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI)

Authors:  C W Hamm; J Reimers; T Ischinger; H J Rupprecht; J Berger; W Bleifeld
Journal:  N Engl J Med       Date:  1994-10-20       Impact factor: 91.245

10.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.

Authors:  Patrick W Serruys; Marie-Claude Morice; A Pieter Kappetein; Antonio Colombo; David R Holmes; Michael J Mack; Elisabeth Ståhle; Ted E Feldman; Marcel van den Brand; Eric J Bass; Nic Van Dyck; Katrin Leadley; Keith D Dawkins; Friedrich W Mohr
Journal:  N Engl J Med       Date:  2009-02-18       Impact factor: 91.245

View more
  136 in total

1.  Coronary artery disease: Risk models for revascularization--the search continues.

Authors:  Seung-Jung Park; Cheol Whan Lee
Journal:  Nat Rev Cardiol       Date:  2012-04-17       Impact factor: 32.419

2.  Constructing an episode of care from acute hospitalization records for studying effects of timing of hip fracture surgery.

Authors:  Katie J Sheehan; Boris Sobolev; Pierre Guy; Eric Bohm; Erik Hellsten; Jason M Sutherland; Lisa Kuramoto; Susan Jaglal
Journal:  J Orthop Res       Date:  2015-08-11       Impact factor: 3.494

3.  Comparing the Cost of Care Provided to Medicare Beneficiaries Assigned to Primary Care Nurse Practitioners and Physicians.

Authors:  Jennifer Perloff; Catherine M DesRoches; Peter Buerhaus
Journal:  Health Serv Res       Date:  2015-12-27       Impact factor: 3.402

4.  Analysis of the bypass angioplasty revascularization investigation trial using a multistate model of clinical outcomes.

Authors:  Xiao Zhang; Quanlin Li; Andre Rogatko; Mourad Tighiouart; Regina M Hardison; Maria Mori Brooks; Sheryl F Kelsey; Sanjay Kaul; C Noel Bairey Merz
Journal:  Am J Cardiol       Date:  2015-02-02       Impact factor: 2.778

Review 5.  Antiplatelet therapy in patients undergoing percutaneous coronary intervention: economic considerations.

Authors:  William S Weintraub; Leonid Mandel; Sandra A Weiss
Journal:  Pharmacoeconomics       Date:  2013-11       Impact factor: 4.981

6.  Alpha-crystallin: an ATP-independent complete molecular chaperone toward sorbitol dehydrogenase.

Authors:  I Marini; R Moschini; A Del Corso; U Mura
Journal:  Cell Mol Life Sci       Date:  2005-03       Impact factor: 9.261

7.  Composite outcomes in coronary bypass surgery versus percutaneous intervention.

Authors:  Fred H Edwards; David M Shahian; Maria V Grau-Sepulveda; Frederick L Grover; John E Mayer; Sean M O'Brien; Elizabeth DeLong; Eric D Peterson; Charles McKay; Richard E Shaw; Kirk N Garratt; George D Dangas; John Messenger; Lloyd W Klein; Jeffrey J Popma; William S Weintraub
Journal:  Ann Thorac Surg       Date:  2014-04-26       Impact factor: 4.330

8.  Impact of drug-eluting stents on the comparative effectiveness of coronary artery bypass surgery and percutaneous coronary intervention.

Authors:  Mark A Hlatky; Derek B Boothroyd; Laurence C Baker; Alan S Go
Journal:  Am Heart J       Date:  2014-10-25       Impact factor: 4.749

Review 9.  Optimal revascularization for complex coronary artery disease.

Authors:  Javaid Iqbal; Patrick W Serruys; David P Taggart
Journal:  Nat Rev Cardiol       Date:  2013-09-17       Impact factor: 32.419

Review 10.  Percutaneous versus surgical interventions for coronary artery disease in those with diabetes mellitus.

Authors:  Ozlem Soran
Journal:  Curr Cardiol Rep       Date:  2013-01       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.